SMTL ID : 6ugv.1 (1 other biounit)

Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a I-centered orthorhombic crystal form, Lot C

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MRY: MESO-ERYTHRITOL(Non-covalent)

MRY.1: 4 residues within 4Å: Chain A: G.141, T.142, T.190, P.192 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.141, A:T.190

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 4 residues within 4Å: Chain A: Y.103, G.104, S.105 Chain B: Y.50 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:Y.103, A:S.105, B:Y.50, B:Y.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lerch, T.F. et al., Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar. BioDrugs (2020)

Release Date

2019-11-13

Peptides

Infliximab Fab Heavy Chain: A
Infliximab Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

Infliximab Fab Heavy Chain

Infliximab Fab Light Chain

Related Entries With Identical Sequence